NASDAQ : CGEM

Cullinan Therapeutics, Inc. — Earnings Estimates

$19.46 USD

$1.18 (6.46%)

Volume
346.72K
Average Volume
933.5K
Market Capitalization
$1.2B
P/E Ratio
-5.77
Dividend Yield
0.00%
Price Target
$33.50
Year High
$19.55
Year Low
$5.68
Day High
—
Day Low
—
Payout Ratio
$0.00
Current Ratio
$8.42

Annual earnings financials

CGEM financial data with annual/quarterly toggle

CGEM GAAP EPS - Annual & Quarterly

CGEM Sales Revenue - Annual & Quarterly

CGEM Shares Outstanding - Annual & Quarterly

Hover over bars to see exact values. Data includes up to 12 years of annual financials and up to 20 quarters of quarterly data from FMP Financial Data.

CGEM Estimated and Actual Revenue by Quarter
CGEM Estimated and Actual EPS by Quarter
CGEM Analyst Forecasts — EBITDA & EBIT
Quarter Date No of Estimates Ebitda Ebit
Low High Average Low High Average
2028-12-30 0 - - - - - -
2028-09-30 0 - - - - - -
2028-06-30 0 - - - - - -
2028-03-30 0 - - - - - -
2027-12-30 1 31.43M 31.43M 31.43M 31.43M 31.43M 31.43M
2027-09-30 1 1.65M 1.65M 1.65M 1.65M 1.65M 1.65M
CGEM Analyst Forecasts — Net Income & SGA Expense
Quarter Date No of Estimates NetIncome SgaExpense
Low High Average Low High Average
2028-12-30 0 -60.56M -60.56M -60.56M - - -
2028-09-30 0 -58.32M -58.32M -58.32M - - -
2028-06-30 0 -56.33M -56.33M -56.33M - - -
2028-03-30 0 -53.81M -53.81M -53.81M - - -
2027-12-30 1 -35.15M -35.15M -35.15M 58.03M 58.03M 58.03M
2027-09-30 1 -52.85M -52.85M -52.85M 3.05M 3.05M 3.05M
CGEM Analyst Forecasts — Revenue & EPS
Quarter Date No of Revenue Estimates Revenue No of EPS Estimates EPS
Low High Average Low High Average
2028-12-30 0 - - - 3 -0.9849 -0.9849 -0.9849
2028-09-30 0 - - - 4 -0.9484 -0.9484 -0.9484
2028-06-30 0 - - - 5 -0.9161 -0.9161 -0.9161
2028-03-30 0 - - - 6 -0.875 -0.875 -0.875
2027-12-30 1 52.39M 52.39M 52.39M 5 -0.57156 -0.57156 -0.57156
2027-09-30 1 2.75M 2.75M 2.75M 2 -0.85946 -0.85946 -0.85946